Xu Jian, Yu Li-xin, Deng Wen-feng, Fu Shao-jie, Du Chuan-fu, Wang Yi-bin, Liu Xiao-you, Miao Yun, Li Chuan-jiang, Ye Jun-sheng
Department of Organ Transplantation, Nanfang Hospital, The Southern Medical University, Guangzhou 510515, China.
Zhonghua Wai Ke Za Zhi. 2006 Feb 1;44(3):157-60.
To investigate the effect of treatment on end-stage liver disease and type-I diabetes mellitus with simultaneous liver-pancreas-duodenum transplantation.
In September 2003, one patient with chronic hepatitis B, liver cirrhosis, hepatic cellular cancer, and insulin-dependent diabetes received simultaneous orthotopic liver and heterotopic pancreas-duodenum transplantation. Liver and pancreas graft function was monitored after transplantation.
The function of pancreas allograft was recovered immediately and the patient became insulin-independence postoperatively. The liver allograft was experienced an acute rejection episode and reversed by intravenous bolus methylprednisolone. The recipient was currently liver disease-free and insulin-free more than 21 months.
The simultaneous liver-pancreas-duodenum transplantation is an effective method in the treatment of end-stage liver disease and type-I diabetes mellitus.